keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Wednesday 11th March - Main Conference Day Two - PT (Pacific Time, GMT-08:00)
keyboard_arrow_leftSearch & Filter
search
Streams
Clear
Formats
Wednesday 11th March - Main Conference Day Two - PT (Pacific Time, GMT-08:00)
search
Streams
Clear
Formats
Showing 1 of 1 Streams
Cell & Gene Therapy Production & Commercialization
8:55am - 9:00am
Chairperson's Opening Remarks: Cell & Gene Therapy Production & Commercialization
9:00am - 9:30am
Scaling genome-edited allogeneic CAR-T manufacturing to increase access to cell therapies
- Engineering strategies for allogeneic CAR-T cell therapies for improved safety and efficacy
- Increasing scale of allogeneic cell therapies without compromising quality
- Improving access to CAR-T therapy with off-the-shelf products
- Justin Scoble - Vice President of Technical Operations, Caribou Biosciences, Inc.
9:30am - 10:00am
Scaling Up Allogeneic Cell Therapy Production
10:00am - 10:30am
Sponsored Talk
Showing 1 of 1 Streams
Cell & Gene Therapy Production & Commercialization
11:15am - 11:45am
From Bench to BLA: Critical Attributes of AAV Vector Manufacturing Process Development
- Mukesh Mayani - Senior Director, Ultragenyx
11:45am - 12:15pm
Topic to be Determined
- Tony Chikere - Director, Sangamo
12:15pm - 12:45pm
Sponsored Talk
Showing 1 of 1 Streams
Cell & Gene Therapy Production & Commercialization
2:00pm - 3:00pm
Improving the Cell Therapy Supply Chain
Case studies on digital platforms, logistics coordination, and AI scheduling algorithms improving vein-to-vein times and reliability.
3:00pm - 3:30pm
Improving the Cell Therapy Supply Chain
Showing 1 of 1 Streams
Cell & Gene Therapy Production & Commercialization
4:15pm - 4:45pm
Next-Generation Formulation Approaches for CGT Products
Presentations on innovative formulations, cryopreservation, and vector stabilization. Talks will highlight predictive modeling and data analytics for stability and manufacturability.
4:45pm - 5:15pm
Panel Discussion: Preparing for Commercialization of Advanced Therapies
Panelists will discuss scaling CGT processes for launch, including validation, comparability, COGS, and supply chain readiness. Focus on digital readiness for regulatory filings and scale-up.
5:15pm - 5:45pm
Quality-by-Design for CGT Formulations: Linking DP Attributes to Clinical Handling
Get the Latest Event Updates
Sign up to get the latest event updates and information.
Filter
Streams
Clear
Formats